Sarah Cannon Outcomes Registry

Withdrawn

• Conditions: Oncology

• Registration Number: NCT02356822
• Lead Sponsor: SCRI Development Innovations, LLC

Brief Summary

This is an investigational multi-site outcomes registry intended to collect information about a patient's cancer care. Patients may enter the Registry at any time during the patient's current stage in the continuum of care. The registries main objectives will be to measure and evaluate the effects of patient care throughout the care continuum, resulting in the identification of the most effective treatment options. Objectives will encompass evaluations and analytics around safety, effectiveness, and improved efficiencies.

Detailed Description

Q

Study Timeline

• Study Start: 2014-12
• Study First Submitted: 2015-01-20
• Study First Submitted QC: 2015-02-04
• Study First Posted: 2015-02-05
• Status Verified: 2019-06
• Primary Completion: 2019-12
• Last Update Submitted: 2023-12-01
• Last Update Posted: 2023-12-05
• Study Completion: 2024-12

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• 18 or older
• Patients that have been diagnosed with/ or are thought to have any form of cancer at any stage in the continuum of their care from screening through survivorship.
• Patient must have the ability to understand the nature of the trial and give written informed consent

Exclusion Criteria

• There are no exclusion criteria for this Outcomes Registry

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Treatment patterns and utilization	5 yrs
quality improvement	10 yrs

Secondary Outcome Measures

Name	Time	Method
Humanistic and economic outcomes	10 yrs

Trial Locations

Locations (1)

SCRI; 🇺🇸 Nashville, Tennessee, United States